Study Evaluates Impact of Highly Active Antiretroviral Therapy (HAART) on Cancer Risk in HIV-infected Men (08/10/2010) Researchers reported that men infected with human immunodeficiency virus (HIV) are still at an increased risk of lymphoma, Kaposi’s sarcoma (KS), and anal cancer despite the introduction of highly active antiretroviral therapy (HAART).
Immunosuppression Increases Risk of HPV-related Cancers in AIDS Patients (08/20/2009) The risk of HPV-related cancers is elevated among AIDS patients. This risk continues to increase as patients’ immune systems become more compromised, according to the results of a study published in the Journal of the National Cancer Institute.
Colorectal Cancer Screening for Individuals with HIV (08/24/2006) According to an article recently published in the Archives of Internal Medicine, patients with the human immunodeficiency virus (HIV) over the age of 50 years may have a higher rate of colon cancer than healthy individuals and should be screened for this disease.
Addition of Rituxan® to CHOP Safe and Effective for AIDS-related NHL (08/16/2006) According to an early online publication in the Journal of Clinical Oncology, the addition of Rituxan® (rituximab) to the chemotherapy combination known as CHOP is safe and effective for the treatment of AIDS-related non-Hodgkin's lymphoma.
Metastat® Shows Promise Against AIDS-related Kaposi’s Sarcoma (03/24/2006) According to the results of a phase II clinical trial published in the Journal of Clinical Oncology, treatment with Metastat® (COL-3) reduced or eliminated detectable Kaposi’s sarcoma in some patients with acquired immune deficiency syndrome (AIDS).
▪ More...